_id
690f3d3dccc777a4e85d1a93
Ticker
CDXS
Name
Codexis Inc
Exchange
NASDAQ
Address
200 Penobscot Drive, Redwood City, CA, United States, 94063
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.codexis.com
Description
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Last Close
1.71
Volume
570024
Current Price
1.67
Change
-2.3391812865497097
Last Updated
2025-11-29T11:18:14.498Z
Image
data:image/webp;base64,UklGRgAKAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSPkFAAABuTJE9D9MVp3/fyPdOem993LSe++N5por77333nvvvU3Z9ZsGv+gwa9nI6OBlI9/ByyyzpWHWstUP5aC/hq0MA5eNzAITZsP3Dqxhqz9K2E/LVn906AkaDQsNs4btHVgLX7P3wJeNzA5M2GhY7sAaNjTMWjYyC1w28iWEjYblDqyFq4gJmIBr4rfztwL8xIXFaPI27iThH/kh/ccYAK8LAbi12yoSKYnzb8sbuIP7uL3v+65vqRjrzgCgyju7o9uRMvqc76hDfDePdHecMFfZ91SR4+jgNSEUaXkXqUoNABDiaz7GJ64B3NfzPJQyPRl+3efNP2n+DTnWluFuP8jDPND9lGEYVblTzd/hK1CbuNy4K8BQBYHB0XLpZzo3UxjePd1DKpnAqO1/SUVcA2BdTxKW6b3c3wNca5J82bt8wshBs4l3+hzbWfszvirKBREoZ0rQqACBpGuoshyUEvk3tbuZ4AbcMuiVyEMAYGYBgAkNU0KozcnkwZ5smH/WG81lI+VDHDzWD3xBljMBBBBgsM5ch2F9VD9RhVKp6RquYU5sj2Lr05YsahjlsKdCMKDHoe84YZ6LnIJNcL2jl/g/Gfbw+GTv3gwAcDunjxe9yk4d86DXsSwmAPFo6/IX9a0slOmjmPWAaNYNGQxiY2KvyqRM7Z7KrU+xIFAUwYEagxnZuN13JAMgQpMEydG43WptxdODpzkxCInZeZb8lfYJUMH2xcgCMfVvPprJhzueTlI3AZgbYQjW49CJKj8EzONAlYndUc645cO1PRfM5B+2I90FYR0JQLV/dDM9w+m2QmH2nih+vTbUiWiBCaPX6PbOUmICrxkDiLPxIsvTjaGbJvZpsdu1nJCLQmbt9lJ60CRR69WqxzjeTlH2JmV0NPsAfW+Y9t8sO/AMYi0I+O12lp7aUqnpSTzbHUUhr+J9GUDD7X/FV3qpgdWV5P0WYv5e/tCITaUdhjX3c+/qgMttT2b7u7Mxu2cg7QBMu3/GC0w5wfCpxDt93HzUGnhgTWF5FE+CiYK9l1weLca+QdB4bI3n7j8GKDuqytqhgOZ00T6nvQDKDYbxzBIMrTPGf9AvBkUB+3p+mz4uRGcUCXVcwrxq9LthfAEItN9NPsWE1WRghjvZBQAst0RnSG5ib4hLS2LNMaKjeDowDayuw1+1Z6yk5Vt9yzgwUZ6oamzFmiL2LtKsL/o34MqEjXJwnG9ZxFqi4Z67XB62ZnlvmCgMr/JWX1NFMX20lb54n53DyijPXEyuk7d0dS2ZndIpBs7+wuqOimt5SLdNyg4jzRCvnoPOnYvGoRXt/of+YnMih78XbzEm1gQhtYees4RpGs5ise+sApXC3jNG7SzUBDi40Zv5MZP3CNgaWf7S2Cxhnq6M5YdFxOtDQGKYQZA6bUDnHLJA3N2RmzZUOj2W3bblMIPXjoHE27xRfUQ3BES++JDEBPpvx08ypAT29WdidMOIsLZEoMRQZTrwElQVIHi5Ew+KAshafl52PJT2dGXojuWHYajrDAY3wgy4wfbxZqBGu1EOMOZ/w4YEIETrTeSLTJngXbzpcYxLrdZiaeVo0uxMpDIYIFEBgB5b80gMUvwC+pcqFUw9KgfBUEECgB6L5SyqQ9x5sX+WSWgdXj60YgZBr85fC6cq+QXA6c7fI32hjgBYBnsbvenKM0T+x1eYEdcZ/C9g1NVRWd2+I00XdfO4fTkyyt5EuVJ5qXKNwkho/HerDpC4HOogEACJxS07s8mZK+sBzuL8rfiZNs8MAAwwwFKCUZ9c6MwCeehk1tIR0gCh4bzqzytB5cQslSulBIigoxGSAAhxd/d8fpT86biUojFAz89/N88nN3U2bBcAEil0rsNwRhFDD2NHZyKSWEuRR91+FBOYlEqShGEeg2sB3f/uOpUf9dk+O9g2CzA3BxDy8fxj9uc+u5PSdZOTAzRo/bsPBjFhPRm64/iZk4UMhoS9AtdiWFu+a5ieSsAAr9UvEgCKI6tydFEaaDBextAmAxC6nutCMJokgLXQIAHcBEPjjN8eAgBWUDgg4AMAALATAJ0BKkAAQAA+tU6eTScjoqIsErsw4BaJbACvP2h516h+Rvss1L+o4wX0dTgPzv7AH6ZdIDzAfs36QH6Ae47/HeoB/jOod9AD9gPTb9iP9xf3V9sNogrQZZWlBmeeK/UA6Rn7Aewt+oy9vosKiKGxsDQd5g+22chcWQY6Nz1fE5qh9RGKDgrMPdzZw8ZO54RfPO9VCPyrlnZPoO4wp7rwlgUcnEAA6O3pZUMxHMjKH9ZJ8QLhZKF1Bzh2FEiDf5MgKXKK1nOiMOeCVpno5ehOzXMfaRYw61St9JNLnIj3Yd+mzWF5Aejb/0N2NcvgGftiS5IVnntMUniKUIDw1YtSp9Knkw9j56ZdBz4TyC8Cj8P7U1zGjxZk55IIamu9TujaagLyr2nZZkTFmqY/FgBKLG46mU3XJqsEOo7+1+3jdX0UhyoqTxZjUQmsdLSVje6ttV3Uxt7u3yZzthtb5lpM+kYl01DJu+leXrruRfDtzkhEn+e1jFhvAUnxN+cZBdIEJPKLLUNtib02f+5MlYL+1AF8NHG/szIJ/Oui79YO5bpZRutJ9n7d1vbzcg+I9UZYNSJMsI1BIdrEu4IkCfPShlrH5VXeCIsJL7HexijCXcoWLn6HYejdl7yytqbwU2UjVv8VLbonreXhwpozTTABUdqo+DN8wUpHtfC/GdyX6gZ8or8YtGhsaaff6XoRl588v4D3mEzeBUMjlse8f/TZLb+vjCs2uk1kssXIXXTM8ZghXIUFZa4iYq46O7/QE/Y+cZltXA1Dyyb+t5S4YR+KbKXY9t79qT2XAH5cVANnupOUpmcwdCAOAYOMIIp7pD3pcB/PxuhJS1MNXFjagBCIdiZF9XC2NDUNvsLUth0OmojZ7eBHU6Yr4jjPnAs8OMMtaLHJetBuAC8Pet5EZNdJdMBI+8+zzvpRYhFU0y/DmvK/jVneJ3M3h1+PlqjiML3sqa4KCo/f5k1/PNhjvn3kPMBZh4KmvAlevg3wrTPKuz5IuPamnvVAT7R5Yj8SDapCcJc2iQoHfmyeblp+y5IP5V4s2y7wZN7RLlShdhiKZXdx4da6brF/4Hx85AVq9MSwg2ffe6xxwxDsNmybcunDnYNKIJMA/tElD8vX79Reb4dpmPomgC/v6eF7ZWAvIQf+lehMAs4TSC2F1hZHZJY4/6J6OMS+KIi+AlWKFCDIENX8kDmf5pxN2Qi9LwXQamdBgpvekEwIW/cxAMg2+VexFDENcdwx2mwK1rOwhQnzezfyW/KysipjSXHeaA4c9DdyK5pDtvcTBHOwVJeBvdlXrgEVeCx7+eOcy+fxqAAA
Ipo Date
2010-04-22T00:00:00.000Z
Market Cap
156261184
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8727272727272727
Sentiment Sources
11
Rating
4.2857
Target Price
6.5833
Strong Buy
4
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8601000
Cost Of Revenue
2465000
Gross Profit
6136000
Operating Expenses
25085000
Operating Income
-18949000
Interest Expense
1292000
Pretax Income
-19607000
Net Income
-19615000
Eps
-0.21733831204086382
Dividends Per Share
-
Shares Outstanding
90324383
Income Tax Expense
8000
EBITDA
-16259000
Operating Margin
-220.31159167538655
Total Other Income Expense Net
-658000
Cash
25836000
Short Term Investments
33350000
Receivables
9733000
Inventories
1936000
Total Current Assets
76192000
Property Plant Equipment
40534000
Total Assets
123961000
Payables
2425000
Short Term Debt
3091000
Long Term Debt
39729000
Total Liabilities
85417000
Equity
38544000
Depreciation
2056000
Change In Working Capital
7282000
Cash From Operations
-7703000
Capital Expenditures
182000
Cash From Investing
6387000
Cash From Financing
-111000
Net Change In Cash
3543000
PE
-
PB
3.910314705271897
ROE
-50.889892071398926
ROA
-15.823525140971755
FCF
-7885000
Fcf Percent
-0.9167538658295546
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8601000
Quarters > 0 > income Statement > cost Of Revenue
2465000
Quarters > 0 > income Statement > gross Profit
6136000
Quarters > 0 > income Statement > operating Expenses
25085000
Quarters > 0 > income Statement > operating Income
-18949000
Quarters > 0 > income Statement > interest Expense
1292000
Quarters > 0 > income Statement > pretax Income
-19607000
Quarters > 0 > income Statement > net Income
-19615000
Quarters > 0 > income Statement > eps
-0.21733831204086382
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
90251000
Quarters > 0 > income Statement > income Tax Expense
8000
Quarters > 0 > income Statement > EBITDA
-16259000
Quarters > 0 > income Statement > operating Margin
-220.31159167538655
Quarters > 0 > income Statement > total Other Income Expense Net
-658000
Quarters > 0 > balance Sheet > cash
25836000
Quarters > 0 > balance Sheet > short Term Investments
33350000
Quarters > 0 > balance Sheet > receivables
9733000
Quarters > 0 > balance Sheet > inventories
1936000
Quarters > 0 > balance Sheet > total Current Assets
76192000
Quarters > 0 > balance Sheet > property Plant Equipment
40534000
Quarters > 0 > balance Sheet > total Assets
123961000
Quarters > 0 > balance Sheet > payables
2425000
Quarters > 0 > balance Sheet > short Term Debt
3091000
Quarters > 0 > balance Sheet > long Term Debt
39729000
Quarters > 0 > balance Sheet > total Liabilities
85417000
Quarters > 0 > balance Sheet > equity
38544000
Quarters > 0 > cash Flow > net Income
-19615000
Quarters > 0 > cash Flow > depreciation
2056000
Quarters > 0 > cash Flow > change In Working Capital
7282000
Quarters > 0 > cash Flow > cash From Operations
-7703000
Quarters > 0 > cash Flow > capital Expenditures
182000
Quarters > 0 > cash Flow > cash From Investing
6387000
Quarters > 0 > cash Flow > cash From Financing
-111000
Quarters > 0 > cash Flow > net Change In Cash
3543000
Quarters > 0 > ratios > PE
-0.21733831204086382
Quarters > 0 > ratios > PB
3.910314705271897
Quarters > 0 > ratios > ROE
-50.889892071398926
Quarters > 0 > ratios > ROA
-15.823525140971755
Quarters > 0 > ratios > FCF
-7885000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.9167538658295546
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
15328000
Quarters > 1 > income Statement > cost Of Revenue
2098000
Quarters > 1 > income Statement > gross Profit
13230000
Quarters > 1 > income Statement > operating Expenses
26092000
Quarters > 1 > income Statement > operating Income
-12862000
Quarters > 1 > income Statement > interest Expense
984000
Quarters > 1 > income Statement > pretax Income
-13262000
Quarters > 1 > income Statement > net Income
-13272000
Quarters > 1 > income Statement > eps
-0.15542985630467623
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
85389000
Quarters > 1 > income Statement > income Tax Expense
10000
Quarters > 1 > income Statement > EBITDA
-11960000
Quarters > 1 > income Statement > operating Margin
-83.91179540709813
Quarters > 1 > income Statement > total Other Income Expense Net
-400000
Quarters > 1 > balance Sheet > cash
26761000
Quarters > 1 > balance Sheet > short Term Investments
39569000
Quarters > 1 > balance Sheet > receivables
16483000
Quarters > 1 > balance Sheet > inventories
1945000
Quarters > 1 > balance Sheet > total Current Assets
88729000
Quarters > 1 > balance Sheet > property Plant Equipment
42244000
Quarters > 1 > balance Sheet > total Assets
138246000
Quarters > 1 > balance Sheet > payables
1468000
Quarters > 1 > balance Sheet > short Term Debt
3001000
Quarters > 1 > balance Sheet > long Term Debt
39373000
Quarters > 1 > balance Sheet > total Liabilities
82615000
Quarters > 1 > balance Sheet > equity
55631000
Quarters > 1 > cash Flow > net Income
-13272000
Quarters > 1 > cash Flow > depreciation
1340000
Quarters > 1 > cash Flow > change In Working Capital
-9320000
Quarters > 1 > cash Flow > cash From Operations
-17967000
Quarters > 1 > cash Flow > capital Expenditures
2513000
Quarters > 1 > cash Flow > cash From Investing
-367000
Quarters > 1 > cash Flow > cash From Financing
26774000
Quarters > 1 > cash Flow > net Change In Cash
8440000
Quarters > 1 > ratios > PE
-0.15542985630467623
Quarters > 1 > ratios > PB
2.5633123618126583
Quarters > 1 > ratios > ROE
-23.85720191979292
Quarters > 1 > ratios > ROA
-9.600277765721973
Quarters > 1 > ratios > FCF
-20480000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.336116910229645
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7543000
Quarters > 2 > income Statement > cost Of Revenue
2732000
Quarters > 2 > income Statement > gross Profit
4811000
Quarters > 2 > income Statement > operating Expenses
25297000
Quarters > 2 > income Statement > operating Income
-20486000
Quarters > 2 > income Statement > interest Expense
942000
Quarters > 2 > income Statement > pretax Income
-20677000
Quarters > 2 > income Statement > net Income
-20688000
Quarters > 2 > income Statement > eps
-0.25103749544958137
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
82410000
Quarters > 2 > income Statement > income Tax Expense
11000
Quarters > 2 > income Statement > EBITDA
-18768000
Quarters > 2 > income Statement > operating Margin
-271.5895532281586
Quarters > 2 > income Statement > total Other Income Expense Net
-191000
Quarters > 2 > balance Sheet > cash
18319000
Quarters > 2 > balance Sheet > short Term Investments
41462000
Quarters > 2 > balance Sheet > receivables
11587000
Quarters > 2 > balance Sheet > inventories
1781000
Quarters > 2 > balance Sheet > total Current Assets
77808000
Quarters > 2 > balance Sheet > property Plant Equipment
43789000
Quarters > 2 > balance Sheet > total Assets
128887000
Quarters > 2 > balance Sheet > payables
6046000
Quarters > 2 > balance Sheet > short Term Debt
2913000
Quarters > 2 > balance Sheet > long Term Debt
29186000
Quarters > 2 > balance Sheet > total Liabilities
79258000
Quarters > 2 > balance Sheet > equity
49629000
Quarters > 2 > cash Flow > net Income
-20688000
Quarters > 2 > cash Flow > depreciation
1909000
Quarters > 2 > cash Flow > change In Working Capital
2767000
Quarters > 2 > cash Flow > cash From Operations
-13798000
Quarters > 2 > cash Flow > capital Expenditures
1256000
Quarters > 2 > cash Flow > cash From Investing
11769000
Quarters > 2 > cash Flow > cash From Financing
1085000
Quarters > 2 > cash Flow > net Change In Cash
-944000
Quarters > 2 > ratios > PE
-0.25103749544958137
Quarters > 2 > ratios > PB
2.7730701807410987
Quarters > 2 > ratios > ROE
-41.685304962824155
Quarters > 2 > ratios > ROA
-16.05126971688378
Quarters > 2 > ratios > FCF
-15054000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.9957576561049981
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
21460000
Quarters > 3 > income Statement > cost Of Revenue
3654000
Quarters > 3 > income Statement > gross Profit
17806000
Quarters > 3 > income Statement > operating Expenses
25147000
Quarters > 3 > income Statement > operating Income
-7341000
Quarters > 3 > income Statement > interest Expense
6421000
Quarters > 3 > income Statement > pretax Income
-10373000
Quarters > 3 > income Statement > net Income
-10376000
Quarters > 3 > income Statement > eps
-0.1276260762607626
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
81300000
Quarters > 3 > income Statement > income Tax Expense
3000
Quarters > 3 > income Statement > EBITDA
-8282000
Quarters > 3 > income Statement > operating Margin
-34.20782851817334
Quarters > 3 > income Statement > total Other Income Expense Net
-3032000
Quarters > 3 > balance Sheet > cash
19264000
Quarters > 3 > balance Sheet > short Term Investments
54194000
Quarters > 3 > balance Sheet > receivables
18884000
Quarters > 3 > balance Sheet > inventories
1799000
Quarters > 3 > balance Sheet > total Current Assets
98772000
Quarters > 3 > balance Sheet > property Plant Equipment
42897000
Quarters > 3 > balance Sheet > total Assets
149011000
Quarters > 3 > balance Sheet > payables
2838000
Quarters > 3 > balance Sheet > short Term Debt
2827000
Quarters > 3 > balance Sheet > long Term Debt
28905000
Quarters > 3 > balance Sheet > total Liabilities
82084000
Quarters > 3 > balance Sheet > equity
66927000
Quarters > 3 > cash Flow > net Income
-10376000
Quarters > 3 > cash Flow > depreciation
-1155000
Quarters > 3 > cash Flow > change In Working Capital
-13624000
Quarters > 3 > cash Flow > cash From Operations
-16468000
Quarters > 3 > cash Flow > capital Expenditures
1774000
Quarters > 3 > cash Flow > cash From Investing
-2863000
Quarters > 3 > cash Flow > cash From Financing
1132000
Quarters > 3 > cash Flow > net Change In Cash
-18199000
Quarters > 3 > ratios > PE
-0.1276260762607626
Quarters > 3 > ratios > PB
2.0286431485050875
Quarters > 3 > ratios > ROE
-15.503458992633764
Quarters > 3 > ratios > ROA
-6.963244324244519
Quarters > 3 > ratios > FCF
-18242000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.8500465983224604
Quarters > 3 > health Score
24
Valuation > metrics > PE
-0.21733831204086382
Valuation > metrics > PB
3.910314705271897
Valuation > final Score
40.89685294728103
Valuation > verdict
30.3% Overvalued
Profitability > metrics > ROE
-50.889892071398926
Profitability > metrics > ROA
-25.744172616547665
Profitability > metrics > Net Margin
-2.280548773398442
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.216090701535907
Risk > metrics > Interest Coverage
-14.66640866873065
Risk > final Score
-41
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.812907904278463
Liquidity > metrics > Quick Ratio
13.461928934010153
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-22
Prev Risks > 1
-57
Prev Risks > 2
25
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:19:33.612Z
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOpaleye management sells Codexis (CDXS) shares for $1.87 million Investing.com
Read more →Opaleye management sells Codexis (CDXS) shares worth $877,846 Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6.5833
Analyst Picks
Strong Buy
4
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 94.14% of the total shares of Codexis Inc
1.
Opaleye Management Inc(13.9585%)
since
2025/06/30
2.
Casdin Capital, LLC(7.9763%)
since
2025/06/30
3.
BlackRock Inc(7.9053%)
since
2025/06/30
4.
FMR Inc(5.1074%)
since
2025/06/30
5.
Vanguard Group Inc(5.084%)
since
2025/06/30
6.
Aberdeen Group PLC(4.6539%)
since
2025/06/30
7.
Nantahala Capital Management, LLC(4.4652%)
since
2025/06/30
8.
Telemark Asset Management, LLC(4.4313%)
since
2025/06/30
9.
Ameriprise Financial Inc(2.8258%)
since
2025/06/30
10.
abrdn Healthcare Investors(2.7748%)
since
2025/08/31
11.
Vanguard Total Stock Mkt Idx Inv(2.6293%)
since
2025/07/31
12.
iShares Russell 2000 ETF(2.2087%)
since
2025/08/31
13.
Geode Capital Management, LLC(2.1911%)
since
2025/06/30
14.
Pier Capital, LLC(2.1217%)
since
2025/06/30
15.
Columbia Small Cap Value Discv A(1.8812%)
since
2025/07/31
16.
Baillie Gifford & Co Limited.(1.8674%)
since
2025/06/30
17.
Columbia Small Cap Value Discovery Fund(1.8294%)
since
2025/06/30
18.
State Street Corp(1.7873%)
since
2025/06/30
19.
abrdn Life Sciences Investors(1.7585%)
since
2025/08/31
20.
Jacobs Levy Equity Management, Inc.(1.3052%)
since
2025/06/30
21.
Fidelity VIP Growth Initial(1.264%)
since
2025/07/31
22.
Fidelity Advisor Equity Growth I(1.2439%)
since
2025/07/31
23.
Vanguard Institutional Extnd Mkt Idx Tr(0.9826%)
since
2025/07/31
24.
Federated Hermes Inc(0.9669%)
since
2025/06/30
25.
Fidelity Small Cap Index(0.9033%)
since
2025/06/30
26.
Renaissance Technologies Corp(0.8369%)
since
2025/06/30
27.
Pier Capital Small Cap Growth Equity(0.7997%)
since
2025/06/30
28.
SEB Nordamerikafond Småbolag(0.7839%)
since
2025/07/31
29.
Prescott Group Capital Management LLC(0.7761%)
since
2025/06/30
30.
Baillie Gifford Global Discovery A Acc(0.7533%)
since
2025/07/31
31.
Northern Trust Corp(0.7302%)
since
2025/06/30
32.
iShares Russell 2000 Growth ETF(0.6794%)
since
2025/08/31
33.
Fidelity Growth Discovery(0.6414%)
since
2025/07/31
34.
Dimensional Fund Advisors, Inc.(0.6338%)
since
2025/06/30
35.
BlackRock Advantage Small Cap Core Instl(0.5841%)
since
2025/07/31
36.
Private Advisor Group, LLC(0.5793%)
since
2025/06/30
37.
Putnam Small Cap Value A(0.571%)
since
2025/07/31
38.
Federated Hermes MDT Small Cap Core IS(0.5574%)
since
2025/06/30
39.
Federated Hermes MDT SCC Institutional(0.5574%)
since
2025/06/30
40.
iShares Biotechnology ETF(0.5296%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.